UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000018188
Receipt No. R000021063
Official scientific title of the study Healing effect of a Vonoprazan or a Lansoprazole for artificial ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Date of disclosure of the study information 2015/07/07
Last modified on 2018/01/05 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Healing effect of a Vonoprazan or a Lansoprazole for artificial ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Title of the study (Brief title) Healing effect of P-CAB for artificial ulcer after ESD.
Region
Japan

Condition
Condition early gastric cancer
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 It is aimed for the decision of appropriate gastric secretion inhibitors for artificial ulcer after endoscopic submucosal dissection in consideration of the CYP2C19 polymorphism.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes The healing rate of artificial ulcer after endoscopic submucosal dissection is evaluated.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Factorial
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 4
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Eradication of H. pylori before ESD.
Vonoprazan is given after ESD.
Interventions/Control_2 Eradication of H. pylori before ESD.
Lansoprazole is given after ESD.
Interventions/Control_3 No eradication of H. pylori before ESD.
Vonoprazan is given after ESD.
Interventions/Control_4 No eradication of H. pylori before ESD.
Lansoprazole is given after ESD.
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. A case included in the adaptation of the ESD treatment that followed "stomach cancer treatment guidelines"
2. A case of H.pylori-positive
3. A case of 20 years or older
4. A case that Performance status (ECOG) is 0, 1 or 2

Key exclusion criteria 1. A case that takes steroid more than 15 mg
2. A case having serious complications (heart failure, renal failure, liver failure, respiratory failure)
3. A case to have an allergy career to a study drug
4. A case that it was not agree by the participation in this clinical study

Target sample size 200

Research contact person
Name of lead principal investigator Akira Andoh
Organization Shiga University of Medical Science
Division name Divison of Gastroenterology
Address Seta Tsukinowa-cho ,Otsu, Shiga
TEL 077-548-2217
Email Andoh@belle.shiga-med.ac.jp

Public contact
Name of contact person Hiromitsu Ban
Organization Shiga University of Medical Science
Division name Division of Digestive Endoscopy
Address Seta Tsukinowa-cho ,Otsu, Shiga
TEL 077-548-2217
Homepage URL
Email hban@belle.shiga-med.ac.jp

Sponsor
Institute Shiga University of Medical Science
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 滋賀医科大学病院

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 07 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 07 Month 07 Day
Anticipated trial start date
2015 Year 07 Month 07 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 07 Month 04 Day
Last modified on
2018 Year 01 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021063